Project manager / Head pK/pd scientist - abx/ biofilm/phage researcher - surveillance lead & GNA NOW Lead scientist/quality manager
Bristol, England
Joined April 2019
- Tweets254
- Following2K
- Followers319
- Likes520
Collaborative research from PKPD lab (Bristol) and Becky Mayer Centre for phage @marthaClokie, is available on @ResearchGate: researchgate.net/publication…
Marie L G Attwood retweeted
💥Drug resistance is rising, yet new antibiotics aren’t keeping pace – putting millions at risk.
GARDP is flipping the traditional R&D model by prioritizing high-burden countries, targeting drug-resistant infections and ensuring access from day one.
THIS IS BIG: gardp.org/about-gardp/
📢 Share this post and join the #ThisIsBig campaign.
#ThisIsBig #AMR
Marie L G Attwood retweeted
At GARDP, we’re changing the way #antibiotics are developed and accessed by
🛡️ Protecting adults from serious bacterial infections
👶 Helping newborns fight sepsis
💊 Treating drug-resistant gonorrhoea
🌍 Overcoming access barriers
🔬 Advancing new antibiotic discoveries
💥#AMR has reached a critical tipping point.
Without urgent action, deaths could rise by 70% by 20250.
We need bold investment in new antibiotics, better access to treatment, and global collaboration—now.
This is BIG.
📢 Share this post and join the #ThisIsBig campaign.
🔗 gardp.org/this-is-big/
#ThisIsBig #AntibioticResistance
A privilege to present our work from the PKPD lab , NBT NHS Trust Bristol at ESCMID global – at Vienna, Austria
Please check out the lasted work driven by Yojana Gadiya et al research . Available on @ResearchGate: researchgate.net/publication…
Marie L G Attwood retweeted
📣📣 Grand Challenge announced 👇🏻: Innovations for Gram-Negative Antibiotic Discovery gcgh.grandchallenges.org/cha…
Find our latest manuscript collaboration. Its been a pleasure working on this project ://www.researchgate.net/publication/388566335_The_pharmacodynamics_of_fosfomycin_in_combination_with_meropenem_against_Klebsiella_pneumoniae_studied_in_an_in_vitro_model_of_infection
Our latest collaboration, #GNANOW researchgate.net/publication…
Marie L G Attwood retweeted
Why @Leicester_Phage - alongside our phage colleagues globally, are doing the work we do articulated in 30 seconds!
One of the major problems facing humanity is the inability to treat bacteria that make us sick.
Prof @MarthaClokie and her Centre for Phage Research team are studying bacteriophages to combat this growing issue.
#CitizensOfChange | #AMRAwarenessWeek | #AMR | @Leicester_Phage
Marie L G Attwood retweeted
Two videos today for our series on the ESCMID/ASM Conference 2024: Alasdair MacGowan presents two works on treatments against Acinetobacter baumannii and NDM producing Escherichia coli.
📺📺 ow.ly/OmQI50Tm0Fx 📺📺
Check out our latest work from Bristol in collaboration with the University of Liverpool, Athens, Patras and Micron Ltd - Population pK/pD of minocycline plus rifampicin in patients with complicated skin and skin structure infections caused by MRSA academic.oup.com/jac/article…
Please look at the latest research produced by the pK/pD lab, Bristol @ResearchGate: researchgate.net/publication…
Marie L G Attwood retweeted
My latest article: Exposure of Escherichia coli to antibiotic-efflux pump inhibitor combinations in a pharmacokinetic model: impact on bacterial clearance and drug resistance. Great collaboration with Tim Opperman and Alasdair MacGowan 🙂 academic.oup.com/jac/advance…
Marie L G Attwood retweeted
It’s out!
🥳🧫⚡️💧💜
We show that #ColdPlasma #PAW can be used as an effective pre-treatment strategy for #biofilm infected #ChronicWounds. We also suss out some of the mechanisms underpinning PAWs antimicrobial/anti-biofilm activity 💪🏽 🌟
New @BiofilmJournal publication by @HKNVee and colleagues on plasma activated water as a pre-treatment strategy in the context of biofilm-infected chronic wounds
sciencedirect.com/science/ar…
Marie L G Attwood retweeted
Thanks everyone who came to the enjoyable + thought provoking 13th Oxford Phage Meeting. This was my concluding remarks - showing how the talks mapped to the which phages to use, how many and how will they interact with their environment. lpmhealthcare.com/phages-202… #PhgOx23
Marie L G Attwood retweeted
Adding either FOF or TOB to C/T at simulated human clinically observed concentrations reduced P. aeruginosa bacterial loads & the risk of C/T resistance when strains had C/T MICs at or above the clinical breakpoint:
doi.org/10.1093/jac/dkad230
@Ree19872 @OUPMedicine #JACNews
